IL-2 or Interleukin 2 is used is a drug used for treating cancer and HIV patients. It is used in hope that it will promote NK (natural killer) cell production. Patients are usually given high toxic dosages of IL-2. Many persons who underwent IL-2 therapy enjoyed dramatic improvement in T-cell count, as well as overall health. However like any other drugs, it comes with serious side-effects. The US Food and Drug Administration (FDA) have concluded that the risks and costs of IL-2 treatment outweighed those benefits.
A separate study was conducted by Dr. Calvin McCausland, Ph.D. and Emma Oganova M.D, Ph.D, on the effectiveness of Transfer Factor and the drug Interleukin-2 in boosting the production of NK cells. The conclusion: Transfer Factor increased NK cell activity by 437%. The drug IL-2 increased NK cell activity only by 389%.
Statements from 3rd-party researchers include the following: “The sample activated NK cell activity more than the Interleukin-2 (IL-2) drug used as the standard. Here, we now refer to your sample as the Golden Interleukin,” stated Dr. Kisielevsky, Russian Academy of Medical Sciences.
ข้อเปรียบเทียบระหว่าง Interleukin-2 กับ Transfer Factor plus
| Interleukin-2 | Transfer Factor Plus | ||||||||
| Cost(ค่าใช้จ่าย) | US$10,000/ dosage | US$61.45/ bottle 60 capsule | |||||||
| Effectiveness in boosting the NK cells(ประสิทธิภาพการเพิ่ม Nk Cell) | 389% | 437% | |||||||
| Toxicity(ความเป็นพิษ) | Yes | 0% Toxicity | |||||||
| Side-Effects(ผลข้างเคียง) | Yes | No | |||||||
TRANSFER FACTOR: CHEAP, EFFECTIVE & ABSOLUTELY ZERO SIDE-EFFECTS!!!
Links:
– to see a study done by Dr. Darryl See, M.D, an Associate Clinical Professor of World Health Organization, on late stage cancer patients.
– to see more clinical abstracts on the effectiveness of transfer factor treatment in various diseases
